BridgeBio Pharma

BBIONasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$13.016 B

$66.58 -0.04%

Close of 21 Sept 2026

Revenue

$502.1M

#1902 by revenue

Earnings

—

Not reported

Shares outstanding

195,487,474

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#26Ascendis Pharma A/SASND$15.6B
#27Summit TherapeuticsSMMT$13.5B
#28BridgeBio PharmaBBIO$13.0B
#29Biomarin PharmaceuticalBMRN$12.4B
#30Corcept TherapeuticsCORT$12.3B

What if BridgeBio Pharma were worth as much as…

Open the what-if tool →

Gold $30.3T

$154,864.42

Per share 2,326× higher

Bitcoin $1.72T

$8,797.51

Per share 132× higher

Nvidia $5.48T

$28,031.76

Per share 421× higher

Or at a round number

$20.0B $50.0B $100.0B $200.0B

Where these numbers come from

Share counts and financials for BridgeBio Pharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.